Home/ Stocks/ ARCT

Arcturus Therapeutics Holdings Inc. Common Stock

ARCT XNAS

$7.41 +1.39 (+22.85%) ▲ 15-min delayed

Open

$6.47

High

$7.56

Low

$6.45

Volume

1.46M

Market Cap

$172.81M

About Arcturus Therapeutics Holdings Inc. Common Stock

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 111 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$2.06M	$-26,964,000	$-0.95
FY 2025	$82.03M	$-65,783,000	$-2.40
Q3 2025	$17.15M	$-13,448,000	$-0.49
Q2 2025	$28.30M	$-9,180,000	$-0.34

Related Market News

No specific coverage for ARCT yet. Check out our latest market news or earnings calendar.

Get ARCT Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Arcturus Therapeutics Holdings Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.